Poseida Therapeutics, Inc. Patent Applications Rejected
18 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2020-11-16: Application 17098974; Invention SITE-SPECIFIC ENZYMES AND METHODS OF USE; Applicant Poseida Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-09-02: Application 16977547; Invention CARTYRIN COMPOSITIONS AND METHODS FOR USE; Applicant Poseida Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-07-10: Application 16925958; Invention COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS; Applicant Poseida Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2020-02-21: Application 16640807; Invention TRANSPOSON SYSTEM AND METHODS OF USE; Applicant Poseida Therapeutics, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2020-11-16 | 17098974 | SITE-SPECIFIC ENZYMES AND METHODS OF USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210062170A1 | Eric M. OSTERTAG Tseten YESHI | United States United States | NOAKES, SUZANNE MARIE |
| 2020-09-02 | 16977547 | CARTYRIN COMPOSITIONS AND METHODS FOR USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210107993A1 | Eric M. OSTERTAG Devon SHEDLOCK | United States United States | ALLEN, MICHAEL D |
| 2020-07-10 | 16925958 | COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200338361A1 | P. Peter GHOROGHCHIAN | United States | PURDY, KYLE A |
| 2020-02-21 | 16640807 | TRANSPOSON SYSTEM AND METHODS OF USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210115453A1 | Devon SHEDLOCK David HERMANSON Eric OSTERTAG Maximilian RICHTER Stacey Ann CRANERT | United States United States United States United States United States | MOSS, NATALIE M |
| 2019-11-06 | 16675530 | COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION OF TUMORS | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20200138716A1 | P. Peter GHOROGHCHIAN | United States | SHOMER, ISAAC |
| 2019-04-04 | 16375807 | TRANSPOSON SYSTEM AND METHODS OF USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190233843A1 | Devon SHEDLOCK David HERMANSON Eric M. OSTERTAG | United States United States United States | NGUYEN, QUANG |
| 2019-01-18 | 16252127 | COMPOSITIONS AND METHODS FOR INDUCING NANOPARTICLE-MEDIATED MICROVASCULAR EMBOLIZATION FOR TUMORS | POSEIDA THERAPEUTICS, INC. | Abandoned -- Failure to Respond to an Office Action | US20200001110A1 | P. Peter GHOROGHCHIAN | United States | PURDY, KYLE A |
| 2019-01-04 | 16315588 | CHIMERIC ANTIGEN RECEPTORS (CARS) SPECIFIC FOR MUC1 AND METHODS FOR THEIR USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190328784A1 | Eric Ostertag Devon Shedlock | United States United States | ROBERTS, ANJEANETTE |
| 2019-01-04 | 16315566 | CHIMERIC ANTIGEN RECEPTORS AND METHODS FOR USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190177421A1 | Eric Ostertag Devon Shedlock | United States United States | HARTNETT, BRIAN |
| 2018-10-08 | 16154478 | METHOD OF TREATING PAIN | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190135759A1 | Eric M. OSTERTAG John Stuart CRAWFORD | United States United States | SEAMAN, D MARGARET M |
| 2017-12-20 | 15849545 | TRANSPOSON SYSTEM AND METHODS OF USE | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190185880A1 | Devon SHEDLOCK David HERMANSON Eric OSTERTAG | United States United States United States | NGUYEN, QUANG |
| 2017-10-23 | 15790792 | MODIFIED STEM CELL MEMORY T CELLS, METHODS OF MAKING AND METHODS OF USING SAME | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20190119636A1 | Eric OSTERTAG Devon SHEDLOCK | United States United States | WEHBE, ANNE MARIE SABRINA |
| 2016-12-30 | 15395942 | BIODEGRADABLE NANOPARTICLES AS NOVEL HEMOGLOBIN-BASED OXYGEN CARRIERS AND METHODS OF USING THE SAME | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170105929A1 | P. Peter Ghoroghchian Eric Ostertag | United States United States | DESAI, ANAND U |
| 2016-12-07 | 15317027 | METHODS AND COMPOSITIONS FOR IN VIVO NON-COVALENT LINKING | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170114149A1 | Eric Ostertag Tseten Yeshi Xianghong Li | United States United States United States | HIBBERT, CATHERINE S |
| 2016-12-07 | 15316967 | A METHOD FOR DIRECTING PROTEINS TO SPECIFIC LOCI IN THE GENOME AND USES THEREOF | Poseida Therapeutics, Inc. | Abandoned -- Failure to Respond to an Office Action | US20170107541A1 | Eric Ostertag Tseten Yeshi Xianghong Li | United States United States United States | ARON, KIMBERLY A |
| 2016-06-30 | 15199021 | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles | POSEIDA THERAPEUTICS, INC | Abandoned -- Failure to Respond to an Office Action | US20170000743A1 | P. Peter Ghoroghchian Jivan Namdeo Yewle | United States United States | LEONARD, ARTHUR S |
| 2014-08-08 | 14455082 | Compositions and Methods for Inducing Nanoparticle-mediated Microvascular Embolization of Tumors | POSEIDA THERAPEUTICS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140363496A1 | P. Peter GHOROGHCHIAN | United States | PURDY, KYLE A |
| 2014-04-25 | 14261540 | Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors | POSEIDA THERAPEUTICS, INC. | Abandoned -- Failure to Respond to an Office Action | US20140255477A1 | P. Peter GHOROGHCHIAN | United States | PURDY, KYLE A |